CS Medica A/S Stock | Price, Analyst Rating & Outlook for 2026

CS Medica A/S

NGM:CSMED

kr 1,01

kr0,00 (0,00%)

1,01 kr

kr0,00 (0,00%)

End-of-day quote: 01/10/2025

CS Medica A/S Stock Value

The analyst rating for NGM:CSMED is currently sf_data unavailable.

CS Medica A/S Company Info

EPS Growth 3Y

0,00%

Market Cap

kr0,01 B

Long-Term Debt

kr0,01 B

Quarterly earnings

11/30/2025

Dividend

kr0,00

Dividend Yield

0,00%

Founded

2011

Industry

Health Care

Country

Denmark

Website

CS Medica A/S

ISIN Number

DK0061668225

Website

http://www.cs-medica.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, CS Medica A/S’s Price Target has risen from kr0,00 to kr1,01 - a 100,00% increase. One analysts predict that CS Medica A/S’s share price will fall in the coming year, reaching kr0,00. This would represent a decrease of -100,00%.

Top growth stocks in the health care sector (5Y.)

What does CS Medica A/S do?

CS Medica A/S engages in the research, development, manufacturing, and commercialization of medical and cannabis-related solutions. Business Segments The company operates primarily in the MedTech industry, focusing on developing cannabinoid-based medical treatments. The company’s business segments can be categorized into Research And Development, Manufacturing, and Commercial Operations. Research And Development The Research And Development segment focuses on discovering, formulating, and va...

CS Medica A/S engages in the research, development, manufacturing, and commercialization of medical and cannabis-related solutions.

Business Segments

The company operates primarily in the MedTech industry, focusing on developing cannabinoid-based medical treatments. The company’s business segments can be categorized into Research And Development, Manufacturing, and Commercial Operations.

Research And Development

The Research And Development segment focuses on discovering, formulating, and validating innovative therapies for various medical conditions.

Manufacturing

The Manufacturing segment operates production facilities.

Commercial Operations

The Commercial Operations segment encompasses the marketing and distribution of the company’s products.

Business Strategy

The company has positioned itself strategically to navigate the complexities of the life sciences sector, with a clear focus on core competencies in science, technology, and knowledge. The company’s strategy reflects its commitment to servicing its patient base while adapting to changing market dynamics.

The company has reframed its strategy to emphasize geographical expansion and broaden patient reach. One of the key aspects of the growth strategy is to reinforce research and development efforts and strengthen intellectual property rights. This approach allows the company to optimize existing resources and mitigate risks associated with dependency on single markets or treatments.

The company also intends to enhance digitalization and a data-centric culture within its operations. The ongoing effort to build awareness and educate stakeholders is reflected in the "Sharing is Caring" concept, which aims to disseminate insights from clinical studies and trials effectively.

Through strategic partnerships and collaborations, the company enhances its research momentum and accelerates product development cycles. Its focus remains on utilizing feedback from clinical trials, which aids in improving product formulations. This patient-centric approach fosters deeper engagement with end-users, ensuring that solutions are responsive to patients' real needs.

Products and Services

The company offers a comprehensive range of products and services that are primarily focused on cannabinoid therapies. The company's treatment portfolio addresses various conditions such as pain management, autoimmune diseases, and stress-related disorders.

The product lines include both medicinal and dermaceutical options tailored for both healthcare providers and consumers. The medicinal products serve as treatments for specific medical conditions, while dermaceutical offerings target cosmetic and skin health-related issues.

In addition to product offerings, the company engages in educational initiatives to raise awareness about cannabinoids’ therapeutic potential. This includes sharing clinical study results and insights into patient experiences.

Geographical Markets Served

The company operates in several key geographical markets, including Europe.

Customers

The company serves a diverse customer base that includes healthcare providers, dispensaries, and end-users seeking effective cannabinoid therapies.

Trade Names

The company has registered trademarks in 17 countries and has secured three patents in Denmark.

Sales and Marketing

The company employs a multi-faceted marketing strategy to reach its target customers effectively. The distribution channels include direct sales through healthcare providers, collaborations with dispensaries, and online platforms for better accessibility. The company emphasizes education and awareness initiatives to empower consumers.

Marketing efforts are bolstered by data-driven insights gained through research and clinical trials, which inform product messaging and customer engagement strategies.

Government Regulations

Compliance with the Medical Device Regulation (MDR) and other legislative requirements is paramount.

History

CS MEDICA A/S was founded in 2011. The company was incorporated in 2011.

New support ticket

Explore

CS Medica A/S Stock Value

CS Medica A/S Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does CS Medica A/S do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

CS Medica A/S Stock Value

CS Medica A/S Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does CS Medica A/S do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.